Fennec Pharmaceuticals Inc. (FENC)
Sells a drug that protects children's hearing during cancer chemotherapy
$9.94-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+26.8%
The outlook
FENC is trading above both its 50- and 200-day moving averages, positioned roughly three-quarters of the way up its 52-week range. Analysts' average price target sits about 58% above the current price. The overall data picture leans bullish based on current positioning and valuation metrics.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range76% of the way from its 52-week low to high
Price targetAvg target +58% vs current price
Analyst price target
~12-month · 6 analysts$15.67average target+57.6% vs now
Now $9.94
Low $13.00High $18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$345.3M
52-wk high
$11.31
52-wk low
$5.65
50-day avg
$9.92
200-day avg
$8.21
Trailing P/E
—